OBJECTIVE: We investigated the relationship between anxiety and event-free survival (ie, composite endpoint of death, emergency department visits, or hospitalizations) for patients with heart failure (HF), and examined whether behavioral and physiologic mechanisms mediate any association between anxiety and outcomes. METHODS: In this longitudinal study, patients with HF completed the anxiety subscale of the Brief Symptom Inventory, and heart-rate variability and plasma norepinephrine levels were measured. Dietary adherence and medication adherence were measured according to 24-hour urine sodium level and the Medication Event Monitoring System, respectively. Patients were followed at least 1 year for event-free survival. RESULTS: In total, 147 patients were enrolled. Patients with high anxiety had a shorter (hazard ratio, 2.2; 95% confidence interval, 1.1-4.3; P = .03) period of event-free survival than patients with lower anxiety. Anxiety independently predicted adherence to medication (P = .008), which in turn predicted event-free survival (hazard ratio, 2.0; 95% confidence interval, 1.2-3.3; P = .008). The effect of anxiety (P = .17) on event-free survival was less significant when the regression model included both anxiety and adherence to medication than when the model only included anxiety (P = .03), indicating that adherence to medication mediated the relationship between anxiety and event-free survival. CONCLUSION: This is the first study to show that nonadherence to medication links anxiety and event-free survival for patients with HF. Interventions that reduce anxiety and improve adherence may benefit outcomes. Published by Mosby, Inc.
OBJECTIVE: We investigated the relationship between anxiety and event-free survival (ie, composite endpoint of death, emergency department visits, or hospitalizations) for patients with heart failure (HF), and examined whether behavioral and physiologic mechanisms mediate any association between anxiety and outcomes. METHODS: In this longitudinal study, patients with HF completed the anxiety subscale of the Brief Symptom Inventory, and heart-rate variability and plasma norepinephrine levels were measured. Dietary adherence and medication adherence were measured according to 24-hour urine sodium level and the Medication Event Monitoring System, respectively. Patients were followed at least 1 year for event-free survival. RESULTS: In total, 147 patients were enrolled. Patients with high anxiety had a shorter (hazard ratio, 2.2; 95% confidence interval, 1.1-4.3; P = .03) period of event-free survival than patients with lower anxiety. Anxiety independently predicted adherence to medication (P = .008), which in turn predicted event-free survival (hazard ratio, 2.0; 95% confidence interval, 1.2-3.3; P = .008). The effect of anxiety (P = .17) on event-free survival was less significant when the regression model included both anxiety and adherence to medication than when the model only included anxiety (P = .03), indicating that adherence to medication mediated the relationship between anxiety and event-free survival. CONCLUSION: This is the first study to show that nonadherence to medication links anxiety and event-free survival for patients with HF. Interventions that reduce anxiety and improve adherence may benefit outcomes. Published by Mosby, Inc.
Authors: Harlan M Krumholz; Joan Amatruda; Grace L Smith; Jennifer A Mattera; Sarah A Roumanis; Martha J Radford; Paula Crombie; Viola Vaccarino Journal: J Am Coll Cardiol Date: 2002-01-02 Impact factor: 24.094
Authors: Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong Journal: Circulation Date: 2008-12-15 Impact factor: 29.690
Authors: Misook L Chung; Terry A Lennie; Marla de Jong; Jia-Rong Wu; Barbara Riegel; Debra K Moser Journal: J Card Fail Date: 2008-03 Impact factor: 5.712
Authors: Christopher S Lee; Jill M Gelow; Quin E Denfeld; James O Mudd; Donna Burgess; Jennifer K Green; Shirin O Hiatt; Corrine Y Jurgens Journal: J Cardiovasc Nurs Date: 2014-07 Impact factor: 2.083
Authors: Christopher S Lee; Shirin O Hiatt; Quin E Denfeld; James O Mudd; Christopher Chien; Jill M Gelow Journal: J Cardiovasc Nurs Date: 2015 Sep-Oct Impact factor: 2.083
Authors: Jeff C Huffman; Christina M DuBois; Carol A Mastromauro; Shannon V Moore; Laura Suarez; Elyse R Park Journal: J Health Psychol Date: 2014-08-11
Authors: Nini H Jonkman; Heleen Westland; Rolf H H Groenwold; Susanna Ågren; Felipe Atienza; Lynda Blue; Pieta W F Bruggink-André de la Porte; Darren A DeWalt; Paul L Hebert; Michele Heisler; Tiny Jaarsma; Gertrudis I J M Kempen; Marcia E Leventhal; Dirk J A Lok; Jan Mårtensson; Javier Muñiz; Haruka Otsu; Frank Peters-Klimm; Michael W Rich; Barbara Riegel; Anna Strömberg; Ross T Tsuyuki; Dirk J van Veldhuisen; Jaap C A Trappenburg; Marieke J Schuurmans; Arno W Hoes Journal: Circulation Date: 2016-02-12 Impact factor: 29.690
Authors: Terry A Lennie; Debra K Moser; Martha J Biddle; Darlene Welsh; Geza G Bruckner; D Travis Thomas; Mary Kay Rayens; Alison L Bailey Journal: Res Nurs Health Date: 2013-01-17 Impact factor: 2.228
Authors: Michael L Alosco; John Gunstad; Courtney Beard; Xiaomeng Xu; Uraina S Clark; Donald R Labbe; Beth A Jerskey; Maura Ladino; Denise M Cote; Edward G Walsh; Athena Poppas; Ronald A Cohen; Lawrence H Sweet Journal: J Geriatr Psychiatry Neurol Date: 2014-07-09 Impact factor: 2.680
Authors: Michael L Alosco; Mary Beth Spitznagel; Manfred van Dulmen; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: Psychosom Med Date: 2012-10-31 Impact factor: 4.312